. /.  WORLD TRADE  
ORGANIZATION  G/TBT/N/CAN/130 
20 June 2005 
 (05-2599) 
Committee on Technical Barriers to Trade Original:   English/ 
 French 
 
 
 
NOTIFICATION 
 
The following notification is being circ ulated in accordance with Article 10.6. 
 
1. Member to Agreement notifying:   CANADA  
If applicable, name of local government involved (Articles 3.2 and 7.2):         
2. Agency responsible:   Department of Health 
Name and address (including telephone and fax numbers, e-mail and web-site 
addresses, if available) of  agency or authority designated to handle comments 
regarding the notification shall be  indicated if different from above:  
Canadian Enquiry Point 
200-270 Albert Street Ottawa, Ontario Canada, K1P 6N7 
Tel:  (+1) 613 238 3222, ext. 479 
Fax:  (+1) 613 569 7808 E-mail:  info@scc.ca 
3. Notified under Article 2.9.2 [  X ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:         
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading. 
ICS numbers may be provided in  addition, where applicable):    
Chemical precursors (ICS:  11.120) 
5. Title, number of pages and language(s) of the notified document:   Proposed Order 
Amending Schedule VI to the Controlled Dr ugs and Substances Act (pages 2098-2110, in 
English and French)  
Proposed Amendment to the Precursor Contro l Regulations (pages 2111-2128, in English 
and French) 
6. Description of content :  The purpose of this proposed initiativ e is to amend Schedule VI to 
the Controlled Drugs and Substances Act  (CDSA) and the Precursor Control Regulations  
(PCR) to strengthen the regulatory framework and minimize any negative impact of the 
Regulations on the legitimate trade of pr ecursors.  Among other things, the proposed 
amendments will add six substances to th e CDSA and the PCR: gamma-butyrolactone 
(GBL), 1,4-butanediol (BDO), red phosphor us, white phosphorus, hypophosphorous acid, 
and hydriodic acid.  
The CDSA prohibits the import, export, and possession for export of precursors, except as 
authorized by regulation.  It also provides the authority to develop regulations governing, 
controlling, limiting and aut horizing the importation into Canada, the exportation from  G/TBT/N/CAN/130 
Page 2  
 
 Canada, the production, packaging, sending, transportation, delivery, sale, provision,  
administration, possession, or obtaining of, or other dealing in any precursor or any class 
thereof.  
The PCR provide a regulatory framework fo r the control and monitoring of precursor 
chemicals frequently used in the cl andestine production of illicit drugs. 
Note:  A notice to interested parties rega rding the proposal to add GBL and BDO to 
Schedule VI of the CDSA was notified under G/TBT/N/CAN/69. 
7. Objective and rationale, including the na ture of urgent problems where applicable:  
Protection of human health and safety 
8. Relevant documents:   Canada Gazette, Part I, 11 June 2005 
9. Proposed date of adoption:   
Proposed date of entry into force:   }not stated 
10. Final date for comments:  25 August 2005 
11. Texts available from:  National enquiry point [  X ] or address, telephone and fax 
numbers, e-mail and web-site addresses, if available of the other body:   
The electronic version of the Canada G azette, Part I can be downloaded at:  
http://canadagazette.gc.ca/ partI/2005/20050611/pdf/g1-13924.pdf